In
the morning sessions, venue is divided into group A and B
Young
Investigator Symposium@9:00-11:50 |
|||
| YIS
Session I |
9:00-10:15 k75l | ||
| Chairs: Keiko Sakai & Takeo Kuwata | |||
 |
O-3-18 |
Yasuhiro
Maruta Kumamoto University, Japan |
Post-attachment neutralization by single-chain variable fragments targeting the V3 loop of HIV-1 envelope |
 |
O-3-19 |
Muntasir
Alam Kumamoto University, Japan |
HIV-1 gp41 mutations against fusion inhibitor C34 showed enhanced sensitivity to neutralizing antibodies. |
 |
O-3-20 |
Eriko
Kudo Kumamoto University, Japan |
Sp1 regulates HIV-1 latency maintaining factor COMMD1 |
 |
O-3-21 |
Macdonald
Mahiti Kumamoto University, Japan |
Nef-induced immune evasion functions of HLA class II-restricted responses. |
 |
O-3-22 |
Daisuke
Mizushima Kumamoto University / NCGM, Japan |
Prognosis of acute HBV infection among HIV-infected patients in Japan |
| 10:15-10:30k15l@ |
Coffee Break | ||
| YIS
Session II |
10:30-11:50 k80l | ||
| Chairs: Shigeyoshi Harada & Kazuaki Monde | |||
 |
O-3-23 |
Hironori
Hayashi NCGM, Japan |
Novel protease inhibitors, which bind to the flap region of HIV-1 protease, strongly inhibit multi-drug resistant HIV-1 variants including darunavir-resistant variants |
 |
O-3-24 |
Masayuki
Amano Kumamoto University, Japan |
Modified P1-Moiety Enhances Antiviral Activity against Drug-Resistant HIV-1 Variants and Central Nervous System (CNS) Penetration Effectiveness of Newly-Generated HIV-1 Protease Inhibitors In Vitro. |
 |
O-3-25 |
Michihiro
Hashimoto Kumamoto University, Japan |
HIV-1 spreads among macrophages by promoting the formation of tunneling nanotubes |
 |
O-3-26 |
Naoki
Kishimoto Kumamoto University, Japan Glyceraldehyde 3-phosphate dehydrogenase acts as a tRNALys3-packaging suppressor |
 |
| Poster
Session II (with Lunch) |
11:50-13:30 k100l | ||
| Chairs: Yasuo Ariumi & Yorifumi Satou | |||
| 11:50-13:30k100l | Lunch, Discussion for posters with oral presentation and Best Poster Award Vote | ||
|
Session
X |
13:30-14:30 k60l | ||
| Chairs: Hiroaki Mitsuya & Shinichi Oka | |||
 |
O-3-27 |
Hiroyuki
Gatanaga NCGM / Kumamoto University, Japan |
Recent progress of ART and clinical research |
 |
O-3-28 |
Masanori
Baba Kagoshima University, Japan |
Development of novel anti-HIV-1 agents: recent progress and future prospect |
| 14:30-14:40 |
Best Paper Award Ceremony | ||
| 14:40-14:45 | Closing Remarks | Shuzo
Matsushita [Director, CAIDS, Kumamoto University] |
|